SYDNEY, AUSTRALIA: Botanix Pharmaceuticals Limited (ASX: BOT), a company that specializes in clinical dermatology, has announced the promotion of Dr Howie McKibbon to the position of Chief Executive Officer, effective from 24 August 2023 (Arizona time). Dr McKibbon has been serving as the Chief Operating Officer of the Company, and he will continue to report…